David Hessl

4.2k total citations
37 papers, 3.2k citations indexed

About

David Hessl is a scholar working on Genetics, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, David Hessl has authored 37 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 26 papers in Cognitive Neuroscience and 18 papers in Molecular Biology. Recurrent topics in David Hessl's work include Genetics and Neurodevelopmental Disorders (35 papers), Autism Spectrum Disorder Research (25 papers) and Mitochondrial Function and Pathology (6 papers). David Hessl is often cited by papers focused on Genetics and Neurodevelopmental Disorders (35 papers), Autism Spectrum Disorder Research (25 papers) and Mitochondrial Function and Pathology (6 papers). David Hessl collaborates with scholars based in United States, Japan and Australia. David Hessl's co-authors include Randi J. Hagerman, Flora Tassone, Elizabeth Berry‐Kravis, Paul J. Hagerman, Andrea Schneider, Susan M. Rivera, Louise W. Gane, Allan L. Reiss, Jim Grigsby and Walter E. Kaufmann and has published in prestigious journals such as PLoS ONE, Brain and PEDIATRICS.

In The Last Decade

David Hessl

37 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hessl United States 26 2.8k 2.0k 1.4k 380 312 37 3.2k
Andrea Schneider United States 30 2.4k 0.9× 1.9k 0.9× 1.4k 1.0× 252 0.7× 339 1.1× 110 3.2k
Ruthie E. Amir Israel 14 4.1k 1.5× 2.3k 1.1× 3.0k 2.1× 541 1.4× 260 0.8× 21 5.1k
N. Carolyn Schanen United States 27 3.1k 1.1× 1.9k 0.9× 2.0k 1.4× 474 1.2× 271 0.9× 45 3.8k
Michele Zappella Italy 30 3.5k 1.3× 2.5k 1.2× 1.5k 1.1× 833 2.2× 147 0.5× 96 4.2k
Louise W. Gane United States 24 3.5k 1.3× 2.1k 1.0× 2.2k 1.5× 245 0.6× 543 1.7× 42 3.9k
W. Ted Brown United States 31 2.5k 0.9× 1.6k 0.8× 1.5k 1.1× 130 0.3× 262 0.8× 97 3.4k
Éric Lemonnier France 23 1.1k 0.4× 1.5k 0.7× 597 0.4× 274 0.7× 596 1.9× 56 2.5k
Olga Peñagarikano Spain 17 1.2k 0.4× 1.2k 0.6× 1.0k 0.7× 154 0.4× 503 1.6× 29 2.6k
Jennifer Reichert United States 15 1.5k 0.5× 1.6k 0.8× 869 0.6× 166 0.4× 190 0.6× 17 2.3k
Lisa S. Freund United States 30 2.3k 0.8× 1.8k 0.9× 1.2k 0.8× 372 1.0× 118 0.4× 54 3.1k

Countries citing papers authored by David Hessl

Since Specialization
Citations

This map shows the geographic impact of David Hessl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hessl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hessl more than expected).

Fields of papers citing papers by David Hessl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hessl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hessl. The network helps show where David Hessl may publish in the future.

Co-authorship network of co-authors of David Hessl

This figure shows the co-authorship network connecting the top 25 collaborators of David Hessl. A scholar is included among the top collaborators of David Hessl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hessl. David Hessl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitt, Lauren, Paul S. Horn, Elizabeth Berry‐Kravis, et al.. (2024). Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change Thresholds. Journal of Autism and Developmental Disorders. 56(4). 1658–1670. 1 indexed citations
2.
Hung, Mei, James A. Bourgeois, Kyoungmi Kim, et al.. (2024). Psychiatric Manifestations in Early to Middle Stages of Fragile X-Associated Tremor-Ataxia Syndrome (FXTAS). Journal of Neuropsychiatry. 37(1). 20–28. 1 indexed citations
3.
Wang, Jun Yi, David Hessl, Flora Tassone, et al.. (2019). Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles. Neurobiology of Aging. 86. 27–38. 11 indexed citations
4.
Dijck, Anke Van, Danh V. Nguyen, Reymundo Lozano, et al.. (2017). A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 9(1). 26–26. 59 indexed citations
5.
Wang, Jun Yi, David Hessl, Randi J. Hagerman, Flora Tassone, & Susan M. Rivera. (2012). Age-Dependent Structural Connectivity Effects in Fragile X Premutation. Archives of Neurology. 69(4). 482–9. 51 indexed citations
6.
Mu, Yi, Flora Tassone, David Hessl, et al.. (2012). Hypertension in FMR1 premutation males with and without fragile X‐associated tremor/ataxia syndrome (FXTAS). American Journal of Medical Genetics Part A. 158A(6). 1304–1309. 36 indexed citations
7.
Hessl, David, Andrea Schneider, Kami Koldewyn, et al.. (2011). Decreased Fragile X Mental Retardation Protein Expression Underlies Amygdala Dysfunction in Carriers of the Fragile X Premutation. Biological Psychiatry. 70(9). 859–865. 80 indexed citations
8.
Schneider, Andrea, Elizabeth Ballinger, Alyssa Chavez, et al.. (2010). Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiology of Aging. 33(6). 1045–1053. 14 indexed citations
9.
Bourgeois, James A., Andreea L. Seritan, David Hessl, et al.. (2010). Lifetime Prevalence of Mood and Anxiety Disorders in Fragile X Premutation Carriers. The Journal of Clinical Psychiatry. 72(2). 175–182. 145 indexed citations
10.
Bourgeois, James A., Sarah M. Coffey, Susan M. Rivera, et al.. (2009). A Review of Fragile X Premutation Disorders. The Journal of Clinical Psychiatry. 70(6). e1–e11. 137 indexed citations
11.
Koldewyn, Kami, David Hessl, John S. Adams, et al.. (2008). Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation. Brain Imaging and Behavior. 2(2). 105–116. 46 indexed citations
12.
Hessl, David, Danh V. Nguyen, Cherie Green, et al.. (2008). A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. Journal of Neurodevelopmental Disorders. 1(1). 33–45. 144 indexed citations
13.
Bourgeois, James A., Jennifer B. Cogswell, David Hessl, et al.. (2007). Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. General Hospital Psychiatry. 29(4). 349–356. 70 indexed citations
14.
Grigsby, Jim, Angela G. Brega, Maureen A. Leehey, et al.. (2007). Impairment of executive cognitive functioning in males with fragile X‐associated tremor/ataxia syndrome. Movement Disorders. 22(5). 645–650. 66 indexed citations
15.
McConkie‐Rosell, Allyn, Liane Abrams, Brenda Finucane, et al.. (2007). Recommendations from Multi‐disciplinary Focus Groups on Cascade Testing and Genetic Counseling for Fragile X‐associated Disorders. Journal of Genetic Counseling. 16(5). 593–606. 48 indexed citations
16.
Greco, Claudia, Robert F. Berman, Richard M. Martin, et al.. (2005). Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 129(1). 243–255. 388 indexed citations
17.
Hessl, David, Flora Tassone, Danuta Z. Loesch, et al.. (2005). Abnormal elevation ofFMR1mRNA is associated with psychological symptoms in individuals with the fragile X premutation. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 139B(1). 115–121. 184 indexed citations
18.
Hessl, David, Bronwyn Glaser, Jennifer Dyer-Friedman, et al.. (2002). Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology. 27(7). 855–872. 99 indexed citations
19.
Glaser, Bronwyn, David Hessl, Cindy Johnston, et al.. (2002). Biological and environmental contributions to adaptive behavior in fragile X syndrome. American Journal of Medical Genetics Part A. 117A(1). 21–29. 48 indexed citations
20.
Johnston, Cindy, Stéphan Eliez, Jennifer Dyer-Friedman, et al.. (2001). Neurobehavioral phenotype in carriers of the fragile X premutation. American Journal of Medical Genetics. 103(4). 314–319. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Schneider Breakdown of academic impact, for papers by Ruthie E. Amir Breakdown of academic impact, for papers by N. Carolyn Schanen Breakdown of academic impact, for papers by Michele Zappella Breakdown of academic impact, for papers by Louise W. Gane Breakdown of academic impact, for papers by W. Ted Brown Breakdown of academic impact, for papers by Éric Lemonnier Breakdown of academic impact, for papers by Olga Peñagarikano Breakdown of academic impact, for papers by Jennifer Reichert Breakdown of academic impact, for papers by Lisa S. Freund
Rankless by CCL
2026